Sabaa International Company for Pharmaceutical and Chemical Industry (EGX: SIPC)
Egypt
· Delayed Price · Currency is EGP 1.390
-0.010 (-0.71%)
At close: Dec 19, 2024
EGX: SIPC Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 15.56 | 13.31 | 18.2 | 45.42 | 69.76 | 67.33 | Upgrade
|
| Revenue Growth (YoY) | 22.35% | -26.88% | -59.93% | -34.89% | 3.60% | 34.02% | Upgrade
|
| Cost of Revenue | 10.08 | 4.86 | 10.89 | 26.67 | 30.03 | 31.35 | Upgrade
|
| Gross Profit | 5.48 | 8.45 | 7.31 | 18.75 | 39.73 | 35.99 | Upgrade
|
| Selling, General & Admin | 6.48 | 6.48 | 5.72 | 9.85 | 19.25 | 17.77 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 0.43 | Upgrade
|
| Operating Expenses | 6.48 | 6.43 | 5.73 | 9.9 | 19.5 | 23.22 | Upgrade
|
| Operating Income | -1 | 2.02 | 1.58 | 8.85 | 20.23 | 12.77 | Upgrade
|
| Interest Expense | -1.38 | -1.36 | -1.07 | -0.65 | -0.66 | -1.69 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.08 | -0 | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.38 | 0.5 | 0.44 | 0.62 | - | - | Upgrade
|
| Pretax Income | -8.08 | 1.16 | 0.96 | 8.81 | 19.56 | 11.08 | Upgrade
|
| Income Tax Expense | 0.5 | 1.02 | 0.94 | 2.03 | 4.42 | 2.49 | Upgrade
|
| Net Income | -8.58 | 0.14 | 0.02 | 6.78 | 15.14 | 8.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.03 | 0.03 | 0 | 1.29 | 3.11 | - | Upgrade
|
| Net Income to Common | -8.61 | 0.11 | 0.01 | 5.49 | 12.04 | 8.59 | Upgrade
|
| Net Income Growth | - | 670.53% | -99.73% | -55.22% | 76.28% | 400.06% | Upgrade
|
| Shares Outstanding (Basic) | 250 | 250 | 250 | 250 | - | 309 | Upgrade
|
| Shares Outstanding (Diluted) | 250 | 250 | 250 | 250 | - | 309 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | - | 0.73% | Upgrade
|
| EPS (Basic) | -0.03 | 0.00 | 0.00 | 0.02 | - | 0.03 | Upgrade
|
| EPS (Diluted) | -0.03 | 0.00 | 0.00 | 0.02 | - | 0.03 | Upgrade
|
| EPS Growth | - | 679.31% | -99.74% | - | - | 396.43% | Upgrade
|
| Free Cash Flow | 8.51 | 0.47 | -17.29 | 3.44 | -15.25 | -1.49 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.00 | -0.07 | 0.01 | - | -0.00 | Upgrade
|
| Gross Margin | 35.22% | 63.52% | 40.17% | 41.28% | 56.95% | 53.45% | Upgrade
|
| Operating Margin | -6.41% | 15.18% | 8.70% | 19.48% | 29.00% | 18.96% | Upgrade
|
| Profit Margin | -55.30% | 0.85% | 0.08% | 12.09% | 17.26% | 12.76% | Upgrade
|
| Free Cash Flow Margin | 54.69% | 3.50% | -94.98% | 7.57% | -21.86% | -2.21% | Upgrade
|
| EBITDA | 1.5 | 4.87 | 5.4 | 12.06 | 22.6 | 14.73 | Upgrade
|
| EBITDA Margin | 9.66% | 36.62% | 29.68% | 26.55% | 32.40% | 21.87% | Upgrade
|
| D&A For EBITDA | 2.5 | 2.85 | 3.82 | 3.21 | 2.38 | 1.96 | Upgrade
|
| EBIT | -1 | 2.02 | 1.58 | 8.85 | 20.23 | 12.77 | Upgrade
|
| EBIT Margin | -6.41% | 15.18% | 8.70% | 19.48% | 29.00% | 18.96% | Upgrade
|
| Effective Tax Rate | - | 87.96% | 98.11% | 23.04% | 22.60% | 22.50% | Upgrade
|
| Advertising Expenses | - | 0.08 | 0.03 | - | - | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.